Dr. John Michael Lock, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 109 Poplar Dr, Mountain City, TX 78610 Phone: 512-262-1126 Fax: 512-262-1126 |
News Archive
GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.
Hutchinson-Gilford progeria syndrome is an extremely rare genetic condition that causes premature and accelerated aging.
Morinaga Milk Industry Co., Ltd., a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve A1 (a.k.a. B. breve MCC1274) is safe and effective for improving memory functions of older adults with suspected mild cognitive impairment (MCI) in a randomized, double-blind, placebo-controlled trial (RCT).
More U.S. babies are getting the benefit of a full-term pregnancy, according to a new government report that shows that 61 percent of births now happen at 39 weeks of pregnancy or later, a five percent increase between 2006 and 2010.
Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Population Health Analytics solution, which delivers enterprise business intelligence to support population health management, risk stratification, pay-for-performance quality measures, capitation, and shared savings adjudication for accountable care organizations and other new payer-provider risk models.
› Verified 3 days ago